Simon Tate

Insider Reports History

Location
Redmond, WA
Signature
/s/ William Cowles, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simon Tate:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eliem Therapeutics, Inc. Director Stock Option (Right To Buy) 10,000 26 Jun 2024 Direct

Insider Reports Filed by Simon Tate

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELYM Eliem Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 28 Jun 2024, 17:13
ELYM Eliem Therapeutics, Inc. 18 May 2023 1 $0 4 Director 22 May 2023, 17:13
ELYM Eliem Therapeutics, Inc. 19 May 2022 1 $0 4 Director 01 Jun 2022, 17:17
ELYM Eliem Therapeutics, Inc. 09 Aug 2021 1 $0 4 Director 11 Aug 2021, 17:17
ELYM Eliem Therapeutics, Inc. 09 Aug 2021 0 $0 3 Director 09 Aug 2021, 18:18